IPO registrations (S-1, F-1) · Registrants
Curanex Pharmaceuticals Inc
- SEC CIK
- 2025942 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2024-10-16, last 2025-07-18; 1 initial registration, 6 amendments
- Outcome
- Final prospectus filed 2025-08-26; declared effective 2025-08-12
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- NV
- Business address
- 2 JERICHO PLAZA,, SUITE101B, Jericho, NY 11753
- EIN
- 83-0741390
- Ticker
- CURX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Curanex Pharmaceuticals Inc on the corporate pages
Offering terms
- Proposed price range
- $4.00–$6.00 per share (S-1/A filed 2025-07-18)
- Final price
- $4.00 per share, within the range (424B4 filed 2025-08-26, an initial public offering)
- Shares sold
- 3,750,000
- Gross proceeds
- $15,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CURX
- Lead underwriters
- Dominari Securities
- Syndicate
- Century Securities, Llc; of Contents; Revere Securities; Pacific Century Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CURANEX PHARMACEUTICALS INC Fuzzy (name and state)
- SEC filer: Curanex Pharmaceuticals Inc EXACT (CIK (EXACT))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-10-16 | S-1 | S-1 (registration) | Curanex Pharmaceuticals Inc | 0001493152-24-041335 ↗ |
| 2024-11-01 | S-1/A | S-1/A (amendment) | Curanex Pharmaceuticals Inc | 0001493152-24-043386 ↗ |
| 2024-11-27 | S-1/A | S-1/A (amendment) | Curanex Pharmaceuticals Inc | 0001493152-24-048072 ↗ |
| 2025-02-14 | S-1/A | S-1/A (amendment) | Curanex Pharmaceuticals Inc | 0001493152-25-006655 ↗ |
| 2025-03-17 | S-1/A | S-1/A (amendment) | Curanex Pharmaceuticals Inc | 0001493152-25-010520 ↗ |
| 2025-07-01 | S-1/A | S-1/A (amendment) | Curanex Pharmaceuticals Inc | 0001641172-25-017373 ↗ |
| 2025-07-18 | S-1/A | S-1/A (amendment) | Curanex Pharmaceuticals Inc | 0001641172-25-020262 ↗ |
| 2025-08-12 | EFFECT | EFFECT (declared effective) | Curanex Pharmaceuticals Inc | 9999999995-25-002569 ↗ |
| 2025-08-26 | 424B4 | 424B4 (final prospectus) | Curanex Pharmaceuticals Inc | 0001493152-25-012350 ↗ |
| 2025-08-26 | 424B4 | 424B4 (final prospectus) | Curanex Pharmaceuticals Inc | 0001493152-25-012351 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-18 | S-1/A | registration statement | $4.00–$6.00 | $4.00 | 3,750,000 | $15,000,000 | Nasdaq CURX | 5 | primary document; range, price sentence, shares headline, proceeds computed, cover names 5 | document ↗ |
| 2025-08-26 | 424B4 | final prospectus | $4.00 | 3,750,000 | $15,000,000 | Nasdaq CURX | 5 | primary document; price sentence, shares headline, proceeds table, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Hao Xiaohui | Director | 1 | 2025 | ||
| Hsu Helen Hong | Director | 1 | 2025 | ||
| Jing Dian Ying | Officer,TenPercentOwner | Secretary | 1 | 2025 | |
| Liu Chang | TenPercentOwner | 1 | 2025 | ||
| Liu Jun | Director,Officer,TenPercentOwner | CEO and President | 1 | 2025 | |
| Xie Liqin | Officer | Chief Operating Officer | 1 | 2025 | |
| Yan Yong | Director | 1 | 2025 | ||
| Zhang Ning | Officer | Chief Technology Officer | 1 | 2025 | |
| Zhong Huijuan | Director,Officer | Chief Science Officer | 1 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CURANEX PHARMACEUTICALS INC | NY | State business registries | name and state |
| SEC filer | Curanex Pharmaceuticals Inc | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NY first:
- SYBLEU Inc NY
- TG THERAPEUTICS, INC. NY
- SIGA TECHNOLOGIES INC NY
- SEELOS THERAPEUTICS, INC. NY
- Protagenic Therapeutics, Inc.\new NY
- XTL BIOPHARMACEUTICALS LTD NY
- PENWEST PHARMACEUTICALS CO NY
- CHEMBIO DIAGNOSTICS, INC. NY
- EYETECH PHARMACEUTICALS INC NY
- INNOVATIVE DRUG DELIVERY SYSTEMS INC NY
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health